Management of atrial fibrillation in patients with congenital heart defects
Expert Review of Cardiovascular Therapy , Volume 13 - Issue 1 p. 57- 66
Due to improved surgical technologies and post-operative care, long-term survival has improved in patients with congenital heart disease. Atrial fibrillation (AF) is increasingly observed in this aging population and is associated with morbidity and mortality; however, reports about the pathophysiology and the outcome of different treatment modalities of AF are still scarce in patients with congenital heart disease. In this review, the authors describe the epidemiology, pathophysiology and outcome of the different therapies of AF in this specific patient population.
|, , , , ,|
|Expert Review of Cardiovascular Therapy|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Teuwen, C.P, Ramdjan, T.T.T.K, & de Groot, N.M.S. (2015). Management of atrial fibrillation in patients with congenital heart defects. Expert Review of Cardiovascular Therapy (Vol. 13, pp. 57–66). doi:10.1586/14779072.2015.986467